(Q33193088)

English

Femtomole Immunodetection of Synthetic and Endogenous Amyloid-β Oligomers and Its Application to Alzheimer's Disease Drug Candidate Screening

scientific article published on January 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Femtomole immunodetection of synthetic and endogenous amyloid-beta oligomers and its application to Alzheimer's disease drug candidate screening (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Femtomole Immunodetection of Synthetic and Endogenous Amyloid-β Oligomers and Its Application to Alzheimer's Disease Drug Candidate Screening (English)

1 reference

10.1385/JMN:20:3:305

https://api.crossref.org/works/10.1385/JMN:20:3:305

12 March 2024

0 references

Alzheimer's disease

0 references

beta-cyclodextrins

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14501013

12 March 2024

William L. Klein

5

object named as

William L Klein

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

author name string

Lei Chang

1

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Lara Bakhos

2

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Zhiqiang Wang

3

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Duane L. Venton

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14501013

12 March 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14501013

12 March 2024

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

full work available at URL

http://www.springerlink.com/index/pdf/10.1385/JMN:20:3:305

1 reference

10.1385/JMN:20:3:305

https://api.crossref.org/works/10.1385/JMN:20:3:305

12 March 2024

Journal of Molecular Neuroscience

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

305-313

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

https://scigraph.springernature.com/pub.10.1385/jmn:20:3:305

0 references

Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/14501013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spatial learning deficit in mice expressing human 751-amino acid beta-amyloid precursor protein.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14501013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oligomerization of beta-amyloid of the Alzheimer's and the Dutch-cerebral-haemorrhage types

1 reference

https://pubmed.ncbi.nlm.nih.gov/14501013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation

1 reference

https://pubmed.ncbi.nlm.nih.gov/14501013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14501013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes

1 reference

https://pubmed.ncbi.nlm.nih.gov/14501013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14501013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

1 reference

https://pubmed.ncbi.nlm.nih.gov/14501013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

1 reference

https://pubmed.ncbi.nlm.nih.gov/14501013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14501013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14501013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models

1 reference

https://pubmed.ncbi.nlm.nih.gov/14501013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14501013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secretase as a target for Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/14501013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An ultrastructural study of amyloid intermediates in A beta1-42 fibrillogenesis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14501013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain

1 reference

https://pubmed.ncbi.nlm.nih.gov/14501013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins

1 reference

https://pubmed.ncbi.nlm.nih.gov/14501013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14501013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum?

1 reference

https://pubmed.ncbi.nlm.nih.gov/14501013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Per-6-substituted beta-cyclodextrin libraries inhibit formation of beta-amyloid-peptide (A beta)-derived, soluble oligomers

1 reference

https://pubmed.ncbi.nlm.nih.gov/14501013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Self-assembly of beta-amyloid 42 is retarded by small molecular ligands at the stage of structural intermediates

1 reference

https://pubmed.ncbi.nlm.nih.gov/14501013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society

1 reference

https://pubmed.ncbi.nlm.nih.gov/14501013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assembly of A beta amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/14501013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oligomerization of endogenous and synthetic amyloid beta-protein at nanomolar levels in cell culture and stabilization of monomer by Congo red.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14501013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/14501013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of amyloid beta protein in cerebrospinal fluid as an aid in the diagnosis of Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/14501013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantification of sub-femtomole amounts of Alzheimer amyloid beta peptides.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14501013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14501013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1385/JMN:20:3:305

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33193088&oldid=2100010907"